Idorsia Pharmaceutical saw the highest growth of 799% in patent filings in March and 99% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 86% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Idorsia Pharmaceutical‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Idorsia Pharmaceutical has been focused on protecting inventions in European Patent Office(EPO) with ten publications in Q1 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 12% filings and 31% grants. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), Australia(AU), and Argentina(AR) patent Office are among the top ten patent offices where Idorsia Pharmaceutical is filings its patents. Among the top granted patent authorities, Idorsia Pharmaceutical has 31% of its grants in European Patent Office(EPO), 19% in Australia(AU) and 19% in South Korea(KR).
F. Hoffmann-La Roche and Pfizer could be the strongest competitors for Idorsia Pharmaceutical
Patents related to rare diseases and addiction lead Idorsia Pharmaceutical's portfolio
Idorsia Pharmaceutical has the highest number of patents in rare diseases followed by, addiction and climate change. For rare diseases, nearly 80% of patents were filed and 67% of patents were granted in Q1 2024.
Petrochemicals related patents lead Idorsia Pharmaceutical portfolio followed by pneumonia, and type 1 diabetes (juvenile diabetes)
Idorsia Pharmaceutical has highest number of patents in petrochemicals followed by pneumonia, type 1 diabetes (juvenile diabetes), meningitis, and bacteremia.
For comprehensive analysis of Idorsia Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
